Insight
Fourier Rehab, a global leader in rehabilitation technology, successfully hosted the Global Partnership Summit (GPS) 2024. This landmark event brought together industry leaders, academicians, and healthcare professionals worldwide to foster collaboration and drive innovation in the global healthcare sector. Held at Fourier’s headquarters in Shanghai, Fourier Rehab aimed to create a dynamic platform for forging [...]
NR Times recently spoke to Dr Tamara Werner-Kiechle, Therapeutic Area Lead for Neuroscience, PH and CVM in Europe, Middle East, and Africa (EMEA). Tamara leads Johnson & Johnson’s medical affairs strategies and operational plans in EMEA. In this interview, Tamara sheds light on why innovation is urgently needed to address the rising rates of psychiatric [...]
By Harpreet Kaur, a physiotherapist, sports exercise specialist, corrective exercise specialist & REPS certified fitness coach.
A new digital platform for managing behavioural assessments in neurorehabilitation is aiming to improve the lives of up to 10 million patients, clinicians and carers over the next 10 years. NR Times finds out more.
Inadequate understanding of behavioural risks among brain injury patients is estimated to cost the NHS £2.5 billion a year through adverse incidents and staff turnover. Current behavioural risk assessments are typically carried out on paper, but wards and staff are extremely busy and this data collection is often slow and inconsistent. To tackle this, award-winning health tech company, Decently, has developed a new platform which aims to streamline and simplify these assessments, using data to support clinicians in making evidence-based care decisions and ultimately, reduce the impact and number of incidents of challenging to manage behaviour. Over the last 15 months, MeloTM, has been developed and rolled out among clinicians at Salford Royal Hospital, to help facilitate better decisions around behavioural management through intuitive data collection, visualisation and advanced analytics. Following a successful pilot programme, the company is now looking to expand into a number of NHS trusts and private healthcare organisations across the UK. Co-founder of Decently, James Burch, and Dr Alistair Teager, consultant clinical neuropsychologist at Salford Royal, tell us more.
NR Times continues its webinar series with an exclusive roundtable exploring the outlook for community care and support. The discussion addresses some of the big challenges facing rehab professionals, as well as the opportunities to innovate in the years ahead. Thank you to our panellists: Stephanie Fleet, Head of Service Development and Customer Relations, Think [...]
Parkinson’s is the most common primary neurodegenerative disease after Alzheimer’s, affecting nearly nine million people around the world. This figure is expected to double by 2040 in line with an ageing population. Rooted in the Nobel Prize-winning research of Professor Arvid Carlsson, who was best known for his work exploring the role of the neurotransmitter dopamine in Parkinson’s, IRLAB, is developing innovative treatments to tackle unmet needs in Parkinson’s and other neurodegenerative conditions. Subscribe to read the full interview
This spring, healthcare professionals will meet outside of the therapy room to explore the benefits that nature connection can bring to their work.
Dr Claire McDonald, a neuropsychologist and one of the organisers of the event, tells NR Times why nature is an untapped resource for neurorehab.
We’ve all felt the relief of leaving our desks and taking a walk to our nearest green space. But the benefits are not just in our head. There is actually a wealth of scientific evidence to support activities such as forest for our mental and physical health, much of this originates from Japan, where forest bathing is an ancient practice and the government now recommends people spend at least two hours in nature per month. Neurons and Nature is a non-profit festival bringing together nature connection, community and clinical practice. The event takes place for the first time at the Down to Earth Project in Murton, Swansea, where experts in nature-based therapies—alongside the nature-curious—will celebrate and showcase the evidence-base on nature therapies and their role in neurorehabilitation. While there are some unique challenges for individuals with neurological conditions in terms of connecting with nature, the benefits can be significant, for them and their caregivers. Subscribe to read our full interview with Dr Claire McDonald, a clinical neuropsychologist and co-founder of the CIC Nature and Neurons.
A brain injury is not only life-changing for survivors themselves, but also for their families and loved ones. In this exclusive webinar, seven expert stakeholders address some of the biggest challenges and explore what more can and should be done to support this community. Thank you to our panel: Mira Bou Akar, Elysium Healthcare Gayathri [...]
A new mental health treatment has been developed for children with epilepsy that enables multiple mental health conditions to be treated at once, instead of having different treatments for different mental health difficulties. The treatment - named the Mental Health Intervention for Children with Epilepsy (MICE) - has been developed by a UCL-led team of [...]
HD Immune is developing a novel monoclonal antibody therapy for Huntington’s disease patients, aiming to interfere with disease progression and delay symptom development.
Discover: - HD Immune's aim to rid the body of mutated protein - What animal model research has demonstrated so far - HD Immune's fundraising plans to advance to clinical trials
